What is Novatross?
Novatross Technology & Consulting operates at the intersection of clinical data standards and enterprise software development. By specializing in HL7 FHIR solutions, the company addresses the critical need for seamless healthcare interoperability. Their service portfolio, which includes Remote Wellness Check-ins and custom workflow automation, is designed to bridge the gap between legacy systems and modern digital health requirements. By providing expert implementation consulting, Novatross enables payers and clinical organizations to optimize patient engagement and streamline operational efficiency, effectively positioning itself as a vital infrastructure partner in the evolving digital health ecosystem.
How much funding has Novatross raised?
Novatross has raised a total of $50K across 1 funding round:
Debt
$50K
Debt (2021): $50K with participation from PPP
Key Investors in Novatross
PPP
Public-Private Partnership
What's next for Novatross?
As Novatross enters this significant Series B/C stage, the strategic focus will likely shift toward scaling its FHIR implementation services and expanding its footprint in the enterprise healthcare market. The recent capital allocation provides the necessary runway to enhance their proprietary software development capabilities and broaden their omnichannel outreach initiatives. Moving forward, the company is expected to prioritize the integration of advanced automation tools to further reduce the friction associated with FHIR adoption, ultimately aiming to set a new benchmark for patient-centric data exchange and clinical operational excellence.
See full Novatross company page
